Kura Oncology Announces Preliminary Data for Menin Inhibitor KO-539 Accepted for Oral Presentation at ASH
SAN DIEGO, Oct. 07, 2020 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the […]
Nephros to Present at MicroCap Rodeo Best Ideas Bowl on October 13th at 11:30 AM ET
SOUTH ORANGE, NJ, Oct. 07, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that […]
Kaleido Biosciences Announces Data from MMT Programs Accepted for Presentation at Upcoming Scientific Conferences
Ex vivo data from candidate KB109, under evaluation in two clinical studies for COVID-19, to be presented at IDWeek 2020Data […]
Saia to Announce Third Quarter 2020 Results on October 29, 2020
JOHNS CREEK, Ga., Oct. 07, 2020 (GLOBE NEWSWIRE) — Saia, Inc. (NASDAQ: SAIA), a leading transportation provider offering multi-regional less-than-truckload […]
Safe-T Listed in Leading Analyst Firm’s Q3 2020 Tech Tide™: Zero Trust Threat Prevention Report
HERZLIYA, Israel, Oct. 07, 2020 (GLOBE NEWSWIRE) — Safe-T® Group Ltd. (NASDAQ, TASE: SFET), a provider of secure access solutions […]
Microbot Medical Receives Notice of Allowance for U.S. Patent Covering a System for Reducing Dialysis Shunt Stenosis
HINGHAM, Mass., Oct. 07, 2020 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT) announced that the United States Patent and […]
Tonix Pharmaceuticals to Participate in BIO Investor Forum Digital
CHATHAM, N.J., Oct. 07, 2020 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage […]
Mondelēz International Invests in Global Center for Sustainable Cocoa Farming Solutions
Cocoa is at the heart of chocolate and demand is growing, with Asia set to become the second largest consumer […]
AGTC Joins the My Retina Tracker® Program as a New Scientific Collaborator
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Oct. 07, 2020 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (AGTC), Blueprint Genetics, and Foundation […]
EyePoint Pharmaceuticals Announces Preliminary Net Product Revenue for Third Quarter 2020
– Q3 2020 net product revenues are estimated to be between $5.5 – $5.9 million, as healthcare facilities began reopening […]
